Can Diverticulitis Affect Your Liver?

Diverticulitis can affect the liver, though it does so uncommonly and through pathways most people would not expect. The colon and liver share a direct plumbing connection: the portal venous system, which carries blood from the intestines to the liver for processing. When inflamed or perforated diverticula allow bacteria to breach the colon wall, those bacteria can travel straight to the liver and cause serious infections there. Beyond this acute route, diverticular disease and liver conditions also overlap in subtler metabolic ways that researchers are still working to untangle.

How Bacteria Get from the Colon to the Liver

The key to understanding the diverticulitis-liver connection is the portal vein. Blood leaving the colon does not head directly back to the heart. Instead, it flows through the portal venous system into the liver first, where the liver filters it before sending it onward. Under normal conditions, the colon’s mucosal lining keeps gut bacteria contained. But diverticulitis, especially when a diverticulum perforates, disrupts that barrier. Once bacteria escape through the damaged colon wall, they enter the small veins draining the area and ride the portal bloodstream into the liver.¹

This is not unique to diverticulitis. Any infection in the territory drained by the portal vein can seed the liver, including appendicitis, inflammatory bowel disease, and pancreatic infections. But diverticulitis is the most common trigger, largely because diverticular disease itself is so prevalent in Western populations and because diverticula tend to form in parts of the colon with rich portal venous drainage.²

Pyogenic Liver Abscess

The most well-documented way diverticulitis harms the liver is by causing a pyogenic liver abscess, which is essentially a pocket of pus that forms inside the liver tissue. This happens when bacteria from the inflamed colon colonize the liver and trigger a walled-off infection. It is rare in absolute terms, but people with diverticular disease face a meaningfully higher risk than the general population. A large nationwide cohort study found that the rate of pyogenic liver abscess was roughly two and a half times higher in people with diverticular disease than in matched controls. That elevated risk held regardless of whether someone had active diverticulitis or just the underlying structural condition of diverticulosis.³

The risk was particularly striking in younger adults. People under 50 with diverticular disease had roughly four times the risk of developing a liver abscess compared with age-matched controls, a larger gap than in older age groups.³ That finding may seem counterintuitive since diverticular disease is far more common in older people, but it likely reflects the fact that a younger person with diverticular disease severe enough to be diagnosed may have a more aggressive form or a less expected vulnerability.

The infections are typically caused by a mix of bacteria. The two organisms found most often in these abscesses are Bacteroides fragilis and Escherichia coli, both common residents of the colon that cause trouble once they escape their normal territory.⁴ Other organisms occasionally show up too. One case report documented a liver abscess caused by Fusobacterium nucleatum linked to sigmoid diverticulitis, illustrating that less typical gut bacteria can also make the journey.⁵

These abscesses are dangerous. A large retrospective study of over 300 patients with pyogenic liver abscess found that about 30% had an unfavorable outcome, whether that meant the initial treatment failed, the abscess recurred, or the patient died. Portal vein thrombosis and infections with drug-resistant organisms were among the strongest predictors of death within three months of diagnosis.⁶ Hepatic abscesses arising specifically from perforated diverticulitis are considered rare but potentially fatal.⁷

Pylephlebitis, the Complication You Have Probably Never Heard Of

Before bacteria even reach the liver to form an abscess, they can cause a separate and equally serious problem in the portal vein itself. Pylephlebitis is an infected blood clot in the portal venous system. The infection starts in the small veins near the inflamed diverticula, then the clot extends into larger branches, most commonly the superior mesenteric vein, and can eventually reach the main portal vein.⁸

The tricky part is that pylephlebitis does not announce itself with obvious symptoms. People typically show up with abdominal pain, fever, and sometimes nausea or vomiting, which are exactly the symptoms you would attribute to the diverticulitis itself. Because the presentation overlaps so heavily with the underlying infection, pylephlebitis is easily missed unless a doctor specifically looks for it with a contrast-enhanced CT scan.⁸ In a review of cases going back several decades, a precipitating abdominal infection was identified in about two-thirds of pylephlebitis patients, with diverticulitis being the most frequent source. Blood cultures were positive in the vast majority of cases, and the infections were frequently caused by multiple types of bacteria at once.²

Even with treatment, pylephlebitis carries a mortality rate of roughly 14%.⁹ That number reflects improvement from the pre-antibiotic era, when portal vein infections were almost universally lethal, but it still makes pylephlebitis a condition worth taking seriously. Treatment centers on long courses of antibiotics, typically at least four to six weeks. Whether to add blood thinners is debated, but the evidence leans toward doing so when it is safe. One study found that patients who received anticoagulation had significantly higher rates of portal vein clot resolution compared with those who did not, and they were also much less likely to develop chronic complications like portal hypertension down the line.¹⁰ Current guidance suggests that anticoagulation should be added when imaging shows the clot is growing or when fever persists despite proper antibiotics.⁹

The Shared Metabolic Ground Between Diverticular Disease and Fatty Liver

Beyond acute infections, there is a quieter and more controversial connection between diverticular disease and the liver: the two conditions seem to show up together in people with metabolic risk factors. Both fatty liver disease and colonic diverticulosis are strongly linked to obesity and excess visceral fat. Researchers have proposed that intestinal dysbiosis, a shift in the balance of gut bacteria, may contribute to both conditions. When the gut microbiome is disrupted, the intestinal barrier becomes leakier, allowing bacterial byproducts to reach the liver more easily and promote inflammation there.¹¹

Studies looking at whether people with diverticula are actually more likely to have fatty liver have returned mixed results, though. Some found that increasing severity of fatty liver correlated with higher odds of diverticulosis, with severe fatty liver disease carrying substantially elevated odds. But at least one study found the opposite: that fatty liver was actually a negative predictor of diverticulosis.¹² These contradictory findings suggest that the relationship, if it exists, is not straightforward. The two diseases likely share underlying drivers like obesity and gut microbiome disruption rather than one directly causing the other.

Research on the gut microbiome in people with diverticula supports the idea that something is off even before diverticulitis develops. Compared to healthy controls, people with diverticula showed a large increase in colonic immune cells called macrophages and depletion of certain beneficial bacterial groups. When symptoms were present, additional bacterial populations were reduced.¹³ Whether these microbiome changes contribute to liver problems in a meaningful way is still an open question. The research is suggestive but far from settled, and anyone claiming a clear causal chain between diverticulosis and fatty liver disease is getting ahead of the data.

When Diverticulitis Mimics a Liver or Gallbladder Problem

There is another way diverticulitis and the liver intersect, and it has nothing to do with actual liver damage. Sometimes diverticulitis itself is mistaken for a liver or gallbladder condition. When inflamed diverticula are located in the right colon, or when the sigmoid colon is unusually long and loops up toward the right side of the abdomen, the resulting pain can settle in the right upper quadrant, exactly where you would expect gallbladder or liver pain. One published case described a 70-year-old woman who arrived at the emergency department with right upper quadrant pain and was initially suspected of having cholecystitis, an inflamed gallbladder. Ultrasound and CT ultimately showed that her sigmoid colon had an anatomical variation that placed inflamed diverticula in the area mimicking gallbladder disease.¹⁴

Misdiagnosis is not rare in right-sided diverticulitis generally. A review of cases in Western countries found that a correct diagnosis was achieved before surgery in fewer than a quarter of cases, while misdiagnosis happened in over a third, most commonly as suspected appendicitis.¹⁵ While appendicitis is the most common mix-up, the gallbladder confusion matters for this discussion because it can lead to unnecessary liver or biliary workups, or even gallbladder removal surgery, when the real problem is further down in the colon.

If you have been told your liver enzymes are elevated or that imaging showed something concerning near your liver during a diverticulitis episode, it is worth making sure the finding actually originates from the liver and is not inflammation from nearby diverticula being misattributed.

Antibiotics for Diverticulitis and Liver Injury

There is one more route by which diverticulitis can affect the liver, and it is entirely iatrogenic, meaning it comes from the treatment rather than the disease. Several antibiotics commonly prescribed for diverticulitis have the potential to cause drug-induced liver injury. Amoxicillin-clavulanate (commonly sold as Augmentin) and the fluoroquinolones ciprofloxacin and levofloxacin have all been linked to liver damage in some patients.¹⁶

Drug-induced liver injury from these antibiotics is not common, and most cases resolve after the medication is stopped. But if you are being treated for diverticulitis and notice new symptoms like dark urine, yellowing of the skin or eyes, unusual fatigue, or right-sided abdominal pain that feels different from your usual diverticulitis, those could be signs of a liver reaction to the medication rather than worsening of the diverticulitis itself. This is especially relevant for people who already have some degree of underlying liver disease, as their liver may tolerate these drugs less well.

It is also worth noting that the medical approach to antibiotic use in uncomplicated diverticulitis has shifted. Many guidelines now permit a watch-and-wait approach for mild cases without antibiotics, which sidesteps the liver injury question entirely for those patients. Antibiotics remain standard for complicated diverticulitis involving abscess, perforation, or other serious findings.

When Surgery Enters the Picture

For people who experience recurrent bouts of diverticulitis, especially those with complications that have already involved the liver or portal venous system, the question of elective surgery comes up. Removing the affected segment of the colon, typically the sigmoid, dramatically reduces recurrence. A randomized trial comparing elective laparoscopic sigmoid resection to continued conservative management found that about 11% of surgery patients had recurrent diverticulitis within two years, compared with 61% in the conservative group.¹⁷ Quality of life scores were also better in the surgery group at the one-year mark, though the groups converged by two years.

For someone who has already developed pylephlebitis or a liver abscess from diverticulitis, these recurrence numbers carry extra weight. Each new episode of diverticulitis is another opportunity for bacteria to seed the portal system. Whether surgery is the right call depends on many individual factors, including the severity and frequency of episodes and the patient’s overall health, but knowing that the disease can affect organs beyond the colon sometimes tilts the conversation toward a more definitive approach.

Why Younger Adults Should Not Assume They Are Low-Risk

Diverticular disease was historically considered an older person’s condition, but its prevalence in younger adults has been rising. And as noted earlier, the relative risk of liver abscess linked to diverticular disease is actually highest in people under 50, not in older populations.³ Younger adults may also be less likely to have diverticulitis complications recognized quickly, precisely because clinicians are not always looking for them in that age group. Right-sided diverticulitis in particular tends to affect younger patients and, as discussed, is frequently misdiagnosed.

If you are under 50 and dealing with recurrent diverticulitis, or if you develop unexplained fevers, elevated liver enzymes, or right-upper-quadrant pain during a flare, it is reasonable to push for imaging that specifically evaluates the portal vein and liver, not just the colon. A contrast CT that captures the venous phase can reveal both pylephlebitis and early abscess formation, and catching either of these early makes a substantial difference in outcomes.

The Gut Microbiome as a Connecting Thread

One of the more interesting research directions ties the diverticulitis-liver question back to the gut microbiome. Diverticular disease is associated with measurable shifts in the bacteria living in the colon, including reductions in groups thought to play anti-inflammatory roles.¹³ These same types of microbiome disruptions have been implicated in fatty liver disease and other liver conditions, because a less diverse and less stable gut bacterial community allows more inflammatory molecules to leak across the intestinal wall and reach the liver through portal circulation.

This does not mean that fixing the microbiome will prevent liver complications from diverticulitis, and no one has demonstrated that probiotics or dietary interventions specifically reduce liver abscess risk in people with diverticular disease. But the shared biology is worth watching. As the science of the gut-liver axis matures, it may eventually inform prevention strategies that address the root vulnerability, a compromised intestinal barrier, rather than just treating the downstream infections after they occur.

1
PubMed Central. Pyogenic Liver Abscess Secondary to Sigmoid Diverticulitis: An Unusual Presentation
2
Oxford Academic. Septic Thrombophlebitis of the Portal Vein (Pylephlebitis): Diagnosis and Management in the Modern Era
3
PubMed Central. Increased Risk of Pyogenic Liver Abscess Among Patients With Colonic Diverticular Diseases: A Nationwide Cohort Study
4
Biomedical Journal of Scientific & Technical Research. Pylephlebitis and Liver Abscess Complicating Diverticulitis
5
PubMed Central. Fusobacterium Nucleatum: Atypical Organism of Pyogenic Liver Abscess Might be Related to Sigmoid Diverticulitis
6
SpringerLink / Infection. Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses
7
PubMed Central. Hepatic Abscess as Early Presentation of Perforated Diverticulitis
8
Journal of Case Reports and Images in Surgery. Pylephlebitis due to complicated diverticulitis: A case report and review of the literature
9
PubMed Central. Pylephlebitis: A Systematic Review on Etiology, Diagnosis, and Treatment of Infective Portal Vein Thrombosis
10
PubMed. The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes
11
PubMed. The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome
12
PubMed Central. Diverticulosis and cardiometabolic risk factors: a systematic literature review
13
Gut. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease
14
PubMed Central. “Sigmoid diverticulitis mimicking cholecystitis” a clinical challenge
15
PubMed Central. Right sided diverticulitis in western countries: A review
16
PubMed Central. Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis: Two Nationwide Cohort Studies
17
JAMA Network. Quality-of-Life and Recurrence Outcomes Following Laparoscopic Elective Sigmoid Resection vs Conservative Treatment Following Diverticulitis